ストックスクリーナーアプリを入手
1.23
9.82%
0.11
アフターアワーズ：
1.37
0.14
+11.38%
前日終値:
$1.12
開ける：
$1.17
24時間の取引高:
841.60K
Relative Volume:
4.76
時価総額：
$5.58M
収益：
-
当期純損益:
$-128.28M
株価収益率:
-0.0201
EPS:
-61.2898
ネットキャッシュフロー:
$-5.26M
1週間 パフォーマンス:
-5.38%
1か月 パフォーマンス:
-52.87%
6か月 パフォーマンス:
-62.87%
1年 パフォーマンス:
-87.60%
1日の値動き範囲:
$0.8757
$1.68
1週間の範囲:
$0.8757
$1.68
52週間の値動き範囲:
$0.8757
$13.28
Lunai Bioworks Inc Stock (LNAI) Company Profile
名前
Lunai Bioworks Inc
セクター
電話
45 39179840
住所
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare LNAI vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
1.23 | 8.75M | 0 | -128.28M | -5.26M | -61.29 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lunai Bioworks Inc (LNAI) 最新ニュース
Lunai Bioworks corrects link in naked short selling lawsuit release - scanx.trade
Lunai Bioworks FY26 Results: Net loss narrows to $3.2M - scanx.trade
Lunai (LNAI) Pulls Back -3.63% From $1.95 Resistance 2026-09-29Breakout Trade - siam.in
Lunai Bioworks (LNAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Parkinson’s Disease Platform Advanced via Exclusive Global Agreement with Tanaist, Inc. Adding Human Cellular Phenotyping for Lunai Bioworks (Nasdaq: LNAI) - conwaydailysun.com
Parkinson's Disease Platform Advanced via Exclusive Global - openpr.com
Lunai Bioworks Inc. (LNAI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lunai Bioworks, Inc. Adds Human Cellular Phenotyping To Its Parkinson's Disease Discovery And Validation Platform And Forms LNAI Pathfinder Consortium - marketscreener.com
Lunai Bioworks Licenses Tanaist’s Cellular Phenotyping Tech to Validate Parkinson’s Findings - GenomeWeb
Lunai Bioworks secures exclusive Tanaist license for Parkinson’s By Investing.com - Investing.com Nigeria
Lunai Bioworks (LNAI) Partners with Tanaist to Advance Parkinson's Disease Research - GuruFocus
Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement - Carroll County Mirror-Democrat
Lunai Bioworks Inc. (LNAI) latest stock news and headlines - Yahoo Finance UK
Lunai Bioworks secures exclusive Tanaist license for Parkinson’s - Investing.com
Lunai Bioworks partners with Tanaist to enhance Parkinson's disease research using human cellular validation. - Pluang
Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement - TradingView
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement - Nasdaq
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Chemical-screening model finds 5.1 times more enzyme-blocking compounds - Stock Titan
Lunai Bioworks shows 5.1-fold enrichment in AI chemical risk screening - scanx.trade
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Treasure Coast News
Lunai Bioworks corrects a link in its lawsuit p... - pluang.com
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint - TradingView
Lunai Bioworks files second amended complaint against six broker-dealers in Delaware - scanx.trade
Lunai Bioworks (LNAI) Surges 9% to $2.40, Testing Key Resistance at $2.52Retail Driven Moves - dars.gov.et
Lunai (LNAI) Earnings Data Review: The Company Reports Its Latest Available Figures in the Latest Reading; Closing Response: The Market Price Declines 3.78% in the Latest ReadingNet Income Trends - vinanet.vn
Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lunai Bioworks (LNAI) Slips 1.44% to $2.40 as Biotech Traders Eye Key $2.28 SupportMomentum Surge Alerts - dars.gov.et
Lunai Bioworks (LNAI) Slips 1.18% as Shares Test Key Support Near $2.39NHNL Divergence - careplusvn.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics - Investing.com
Lunai Bioworks files amended complaint alleging naked short selling - Investing.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics By Investing.com - Investing.com UK
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - 富途牛牛
Lunai Bioworks files amended complaint alleging naked short selling By Investing.com - Investing.com India
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - Yahoo Finance
LNAI Q2 2026 Earnings: Biotech Posts $0.08 Per-Share Loss; Stock Retreats 3.96%Return On Capital - careplusvn.com
LNAI Q2 2026 Earnings: Reported Loss of -$0.08 Per Share as Stock Climbs 5.45%Analyst Earnings Estimate - vinanet.vn
Lunai Bioworks (LNAI) Declines 4.27%, Testing Key Support Near $1.92Unusual Put Volume - dars.gov.et
LNAI: Lunai Bioworks Inc.Financial Overview - Zacks Investment Research
Lunai Bioworks Holds Steady at $2.24: Consolidation Phase Amid Key SupportVolume Climax - careplusvn.com
LNAI|Lunai Bioworks Ord Shs|Price:2.240|Chg%:-0.090 - TradingKey
Lunai Bioworks Ord Shs (LNAI) Institutional Confidence - TradingKey
Lunai Bioworks Inc. Revenue Breakdown – NASDAQ:LNAI - TradingView
Lunai Bioworks Ord Shs (LNAI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lunai Bioworks(LNAI) Stock Options Chain | Quotes & News - Moomoo
Lunai Bioworks Inc. (LNAI) investor group discloses 9.41% stake in Schedule 13G - Stock Titan
Lunai Bioworks (LNAI) Tests Key Support After 3.4% DeclineTICK Divergence - careplusvn.com
LNAI Q2 2026 Earnings: Pre-Revenue Biotech Reports Loss of $0.08 Per Share; Stock Climbs 5.3 PointsROA Comparison - vinanet.vn
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Shares SlideEarnings Miss Streak - dars.gov.et
LNAI Q2 2026 Earnings: Biotech Reports Narrowing Loss, Shares Rise 7.1%Debt Analysis Report - dars.gov.et
Lunai Bioworks Inc (LNAI) 財務データ
収益
当期純利益
現金流量
EPS
5.32%
大文字化:
|
ボリューム (24 時間):